Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BREAST CANCER AND EXERCISE BREX: A Multicenter Phase III Open Randomised Trial of the Efficacy of Exercise in the Prevention of Long-term Adverse Effects of Adjuvant Treatments and Breast Cancer Recurrences in Women With Primary Breast Cancer.

NCT00639210 is registered in ClinicalTrials.gov with Finnish Breast Cancer Group as lead sponsor.

NCT NCT00639210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00639210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BREAST CANCER AND EXERCISE BREX: A Multicenter Phase III Open Randomised Trial of the Efficacy of Exercise in the Prevention of Long-term Adverse Effects of Adjuvant Treatments and Breast Cancer Recurrences in Women With Primary Breast Cancer.
Lead sponsor
Finnish Breast Cancer Group
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
September 30, 2007
Enrollment
573 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

help the patients to return to working life, improve quality of life, improve weight control, and muscular and cardiovascular fitness, prevent osteoporosis and osteoporotic fractures, reduce all-cause mortality in patients with primary breast cancer, reduce the risk of breast cancer recurrence